These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 8735822

  • 1. Redistribution of membrane glycoproteins in platelets activated under flow conditions.
    Lozano M, Escolar G, White JG, Tàssies D, Ordinas A, Díaz-Ricart M.
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):214-7. PubMed ID: 8735822
    [Abstract] [Full Text] [Related]

  • 2. Modifications in accessibility of membrane glycoproteins, binding of specific ligands and coagulation factor V during the activation of platelets in blood emerging from bleeding time wounds.
    Escolar G, Lozano M, Díaz-Ricart M, Rao GH, Ordinas A, White JG.
    Am J Hematol; 1999 Apr; 60(4):260-7. PubMed ID: 10203098
    [Abstract] [Full Text] [Related]

  • 3. Dynamic redistribution of major platelet surface receptors after contact-induced platelet activation and spreading. An immunoelectron microscopy study.
    Kieffer N, Guichard J, Breton-Gorius J.
    Am J Pathol; 1992 Jan; 140(1):57-73. PubMed ID: 1309961
    [Abstract] [Full Text] [Related]

  • 4. Fate of the GPIb/IX receptor complex following activation of human platelets.
    White JG, Escolar G.
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):262-5. PubMed ID: 8735835
    [Abstract] [Full Text] [Related]

  • 5. von Willebrand factor competes with fibrin for occupancy of GPIIb:IIIa on thrombin-stimulated platelets.
    Hantgan RR, Nichols WL, Ruggeri ZM.
    Blood; 1990 Feb 15; 75(4):889-94. PubMed ID: 2302458
    [Abstract] [Full Text] [Related]

  • 6. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM, Kasirer-Friede A, Goldsmith HL, Brown EA.
    Thromb Haemost; 1997 Mar 15; 77(3):568-76. PubMed ID: 9066012
    [Abstract] [Full Text] [Related]

  • 7. Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba.
    Pontiggia L, Steiner B, Ulrichts H, Deckmyn H, Forestier M, Beer JH.
    Thromb Haemost; 2006 Dec 15; 96(6):774-80. PubMed ID: 17139372
    [Abstract] [Full Text] [Related]

  • 8. Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders.
    Jensen MK, de Nully Brown P, Lund BV, Nielsen OJ, Hasselbalch HC.
    Br J Haematol; 2000 Jul 15; 110(1):116-24. PubMed ID: 10930987
    [Abstract] [Full Text] [Related]

  • 9. Influence of stent length and heparin coating on platelet activation: a flow cytometric analysis in a pulsed floating model.
    Beythien C, Gutensohn K, Bau J, Hamm CW, Kühnl P, Meinertz T, Terres W.
    Thromb Res; 1999 Apr 15; 94(2):79-86. PubMed ID: 10230892
    [Abstract] [Full Text] [Related]

  • 10. [Impact of shear stress on expression of platelet membrane glycoproteins].
    Li M, Cong Y, Deng X, Hu J, Qin X.
    Zhonghua Yi Xue Za Zhi; 2002 Feb 25; 82(4):267-70. PubMed ID: 11953177
    [Abstract] [Full Text] [Related]

  • 11. [Chronic peripheral arterial occlusive disease, platelet glycoproteins GPIIb-IIIa and GP Ib-IX, plasma von Willebrand factor and plasma fibrinogen concentrations in patients with type 2 diabetes mellitus].
    Gosk-Bierska I, Adamiec R, Doskocz W, Ciosek W.
    Pol Arch Med Wewn; 2000 Feb 25; 103(3-4):139-45. PubMed ID: 11236240
    [Abstract] [Full Text] [Related]

  • 12. Flow cytometric analysis of platelets from children with the Wiskott-Aldrich syndrome reveals defects in platelet development, activation and structure.
    Semple JW, Siminovitch KA, Mody M, Milev Y, Lazarus AH, Wright JF, Freedman J.
    Br J Haematol; 1997 Jun 25; 97(4):747-54. PubMed ID: 9217172
    [Abstract] [Full Text] [Related]

  • 13. The effects of nitric oxide (NO) on platelet membrane receptor expression during activation with human alpha-thrombin.
    Keh D, Gerlach M, Kürer I, Seiler S, Kerner T, Falke KJ, Gerlach H.
    Blood Coagul Fibrinolysis; 1996 Sep 25; 7(6):615-24. PubMed ID: 8899151
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets.
    McKenzie ME, Malinin AI, Bell CR, Dzhanashvili A, Horowitz ED, Oshrine BR, Atar D, Serebruany VL.
    Blood Coagul Fibrinolysis; 2003 Apr 25; 14(3):249-53. PubMed ID: 12695747
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of amphotericin B and fluconazole on platelet membrane glycoproteins.
    Sloand EM, Kumar P, Yu M, Klein HG.
    Transfusion; 1994 May 25; 34(5):415-20. PubMed ID: 8191567
    [Abstract] [Full Text] [Related]

  • 19. Profound inhibition of GPIb, GPIIb/IIIa, PECAM-1, CD63, and CD107 in a chronic drug addict: selecting controls for platelet flow cytometry in the inner city hospital.
    Bell CR, Horowitz ED, Oshrine BR, Serebruany VL.
    Thromb Res; 2001 Feb 01; 101(3):217-8. PubMed ID: 11291427
    [No Abstract] [Full Text] [Related]

  • 20. Platelet activation in flowing blood passing growing arterial thrombi.
    Hagberg IA, Roald HE, Lyberg T.
    Arterioscler Thromb Vasc Biol; 1997 Jul 01; 17(7):1331-6. PubMed ID: 9261264
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.